Question

In: Accounting

Klyne Corporation manufactures pharmaceutical products that are sold through a network of sales agents. The agents...

Klyne Corporation manufactures pharmaceutical products that are sold through a network of sales agents. The agents are paid a commission of 24% of sales. The income statement for the year ending December 31, 2017, is as follows:

KLYNE CORPORATION
Income Statement
For the Year Ending December 31, 2017

  Sales $ 29,000,000
  Cost of goods sold
     Variable $ 14,790,000   
     Fixed 2,876,000    17,666,000
  Gross margin 11,334,000
  Selling and marketing expenses
     Commissions 6,960,000   
     Fixed costs 3,270,000    10,230,000
  Operating income $ 1,104,000
Klyne is considering hiring its own sales staff to replace the network of agents. Klyne will pay its salespeople a commission of 12% and incur fixed costs of $2,086,000.
Required:
1. Calculate Klyne Corporation’s break-even point in sales dollars for the year 2017. (Round your answer to 2 decimal places.)
2. Calculate Klyne Corporation’s break-even point in sales dollars for the year 2017 if the company had hired its own sales force to replace the network of agents. (Round your answer to 2 decimal places.)
3. Calculate the degree of operating leverage at sales of $29,000,000, considering (a) Klyne uses sales agents and (b) Klyne employs its own staff. Describe the advantages and disadvantages of each alternative. (Round your answers to 2 decimal places.)
4. If Klyne increases the commission paid to its sales staff to 10%, keeping all other costs the same, how much revenue (in dollars) would Klyne have to generate to earn the same operating income it did in 2017? (Round your answer to 2 decimal places.)

Solutions

Expert Solution

Solution:

Exisiting contribution margin = Sales - Variable cost = $29,000,000 - ($14,790,000 + $6,960,000) = $7,250,000

Contribution margin ratio = $7,250,000 / $29,000,000 = 25%

Fixed costs = $2,876,000 + $3,270,000 = $6,146,000

Breakeven point in sales dollars = Fixed cost / contribution margin ratio = $6,146,000 / 25% = $24,584,000

Solution 2:

New contribution margin for 2017 = $29,000,000 - ($14,790,000 + $29,000,000*12%) = $10,730,000

New contribution margin ratio = $10,730,000 / $29,000,000 = 37%

New Fixed costs = $6,146,000 + $2,086,000 = $8,232,000

New break even point in sales dollar = $8,232,000 / 37% = $22,248,664.86

Solution 3:

Operating leverage if Klyne uses sales agents:

Operating income = $1,104,000

Contribution margin = $7,250,000

Operating leverage = Contribution / Net operating income = $7,250,000 / $1,104,000 = 6.57

Operating leverage if Klyne employs its own staff:

Operating income = $10,730,000 - $8,232,000 = $2,498,000

Conribution margin = $10,730,000

Operating leverage = $10,730,000 / $2,498,000 = 4.30

Advantage and disvantage of sales agent alternative:

In this alternative, all commissions paid to sales agent are variable with sales, if agent make more sales they will earn more commission. commission rate is also high i.e. 24% of sales. The main advantage is this method of commission encourge agent to do more sale to earn sales commission. As sale is more than company will earn more operating income. Fruther this alternative is having high degree of operating leverage, it means after breakeven, operating income will increase at a very high speed.

The disadvantge of this method is that its breakeven point is very high due to low contribution margin ratio. Company is to acheive high level of sale in order to breakevent.

Advantage and disadvantage of sales staff alternative:

The adavantage of this method is, in this method variable cost is at lower side, resulting in high contribution margin ratio, but fixed costs are high as compared to sales agent alternative.

Solution 4:

Revised contributon margin = $29,000,000 - ($14,790,000 + $29,000,000*10%) = $11,310,000

New contribution margin ratio = $11,310,000 / $29,000,000 = 39%

Desired operating income = $1,104,000

Fixed costs = $8,232,000

Desired contribution margin = $1,104,000 + $8,232,000 = $9,336,000

Revenue required to earn same operating income = Desired contributiom margin / contribution margin ratio

= $9,336,000 / 39% = $23,938,461.54


Related Solutions

Klyne Corporation manufactures pharmaceutical products that are sold through a network of sales agents. The agents...
Klyne Corporation manufactures pharmaceutical products that are sold through a network of sales agents. The agents are paid a commission of 24% of sales. The income statement for the year ending December 31, 2017, is as follows: KLYNE CORPORATION Income Statement For the Year Ending December 31, 2017   Sales $ 29,000,000   Cost of goods sold      Variable $ 14,790,000         Fixed 2,876,000    17,666,000   Gross margin 11,334,000   Selling and marketing expenses      Commissions 6,960,000         Fixed costs 3,270,000    10,230,000   Operating income...
Lionel Corporation manufactures pharmaceutical products sold through a network of sales agents in the United States...
Lionel Corporation manufactures pharmaceutical products sold through a network of sales agents in the United States and Canada. The agents are currently paid an 18% commission on sales; that percentage was used when Lionel prepared the following budgeted income statement for the fiscal year ending June 30, 2019: Lionel Corporation Budgeted Income Statement For the Year Ending June 30, 2019 ($000 omitted) Sales $ 28,500 Cost of goods sold Variable $ 12,825 Fixed 3,500 16,325 Gross profit $ 12,175 Selling...
Lionel Corporation manufactures pharmaceutical products sold through a network of sales agents in the United States...
Lionel Corporation manufactures pharmaceutical products sold through a network of sales agents in the United States and Canada. The agents are currently paid an 18% commission on sales; that percentage was used when Lionel prepared the following budgeted income statement for the fiscal year ending June 30, 2019: Lionel Corporation Budgeted Income Statement For the Year Ending June 30, 2019 ($000 omitted) Sales $ 30,100 Cost of goods sold Variable $ 13,545 Fixed 3,612 17,157 Gross profit $ 12,943 Selling...
Lionel Corporation manufactures pharmaceutical products sold through a network of sales agents in the United States...
Lionel Corporation manufactures pharmaceutical products sold through a network of sales agents in the United States and Canada. The agents are currently paid an 18% commission on sales; that percentage was used when Lionel prepared the following budgeted income statement for the fiscal year ending June 30, 2019: Lionel Corporation Budgeted Income Statement For the Year Ending June 30, 2019 ($000 omitted) Sales $ 30,200 Cost of goods sold Variable $ 13,590 Fixed 3,624 17,214 Gross profit $ 12,986 Selling...
Lionel Corporation manufactures pharmaceutical products sold through a network of sales agents in the United States...
Lionel Corporation manufactures pharmaceutical products sold through a network of sales agents in the United States and Canada. The agents are currently paid an 18% commission on sales; that percentage was used when Lionel prepared the following budgeted income statement for the fiscal year ending June 30, 2019: Lionel Corporation Budgeted Income Statement For the Year Ending June 30, 2019 ($000 omitted) Sales $ 30,200 Cost of goods sold Variable $ 13,590 Fixed 3,624 17,214 Gross profit $ 12,986 Selling...
Lionel Corporation manufactures pharmaceutical products sold through a network of sales agents in the United States...
Lionel Corporation manufactures pharmaceutical products sold through a network of sales agents in the United States and Canada. The agents are currently paid an 18% commission on sales; that percentage was used when Lionel prepared the following budgeted income statement for the fiscal year ending June 30, 2019 Lionel Corporation Budgeted Income Statement For the Year Ending June 30, 2019 ($000 omitted) Sales $ 29,000 Cost of goods sold Variable $ 13,050 Fixed 3,480 16,530 Gross profit $ 12,470 Selling...
Lionel Corporation manufactures pharmaceutical products sold through a network of sales agents in the United States...
Lionel Corporation manufactures pharmaceutical products sold through a network of sales agents in the United States and Canada. The agents are currently paid an 18% commission on sales; that percentage was used when Lionel prepared the following budgeted income statement for the fiscal year ending June 30, 2019: Lionel Corporation Budgeted Income Statement For the Year Ending June 30, 2019 ($000 omitted) Sales $ 30,200 Cost of goods sold Variable $ 13,590 Fixed 3,624 17,214 Gross profit $ 12,986 Selling...
Bonita Beauty Corporation manufactures cosmetic products that are sold through a network of sales agents. The...
Bonita Beauty Corporation manufactures cosmetic products that are sold through a network of sales agents. The agents are paid a commission of  19% of sales. The income statement for the year ending December 31, 2020, is as follows. BONITA BEAUTY CORPORATION Income Statement For the Year Ended December 31, 2020 Sales $ 78,400,000 Cost of goods sold     Variable $ 32,144,000     Fixed 9,000,000 41,144,000     Gross margin $ 37,256,000 Selling and marketing expenses     Commissions $ 14,896,000     Fixed costs 10,528,000 25,424,000     Operating income $...
Marigold Beauty Corporation manufactures cosmetic products that are sold through a network of sales agents. The...
Marigold Beauty Corporation manufactures cosmetic products that are sold through a network of sales agents. The agents are paid a commission of 22% of sales. The income statement for the year ending December 31, 2020, is as follows. MARIGOLD BEAUTY CORPORATION Income Statement For the Year Ended December 31, 2020 Sales $75,100,000 Cost of goods sold     Variable $32,293,000     Fixed 8,870,000 41,163,000     Gross margin $33,937,000 Selling and marketing expenses     Commissions $16,522,000     Fixed costs 10,380,000 26,902,000     Operating income $7,035,000 The company is...
Bonita Beauty Corporation manufactures cosmetic products that are sold through a network of sales agents. The...
Bonita Beauty Corporation manufactures cosmetic products that are sold through a network of sales agents. The agents are paid a commission of 21% of sales. The income statement for the year ending December 31, 2020, is as follows. BONITA BEAUTY CORPORATION Income Statement For the Year Ended December 31, 2020 Sales $78,800,000 Cost of goods sold     Variable $31,520,000     Fixed 8,650,000 40,170,000     Gross margin $38,630,000 Selling and marketing expenses     Commissions $16,548,000     Fixed costs 10,970,900 27,518,900     Operating income $11,111,100 The company is...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT